Skip to main content
. 2019 Dec 9;58(Suppl 7):vii1–vii6. doi: 10.1093/rheumatology/kez402

Fig. 1.

Fig. 1

Diagram of the interplay between CD28 and CTLA-4 and their shared ligands and PD-1/PD-L1

Blockade of inhibitory checkpoints with specific antibodies leads to release of T cell activation.